0002063816 2026-01-01 2026-03-31 0002063816 2025-01-01 2025-03-31 0002063816 us-gaap:FairValueInputsLevel1Member 2025-12-31 0002063816 us-gaap:FairValueInputsLevel1Member 2026-03-31 0002063816 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-01 2026-03-31 0002063816 2025-07-11 0002063816 us-gaap:IPOMember 2026-03-31 0002063816 us-gaap:CommonStockMember 2025-12-31 0002063816 us-gaap:CommonStockMember 2026-03-31 0002063816 2026-03-31 0002063816 inacu:UnderwritingAgreementMember 2026-01-01 2026-03-31 0002063816 inacu:UnderwritingAgreementMember 2026-03-31 0002063816 us-gaap:OverAllotmentOptionMember inacu:UnderwritingAgreementMember 2026-03-31 0002063816 us-gaap:OverAllotmentOptionMember inacu:UnderwritingAgreementMember 2026-01-01 2026-03-31 0002063816 2025-06-30 2025-06-30 0002063816 inacu:WorkingCapitalLoanMember us-gaap:RelatedPartyMember 2026-03-31 0002063816 us-gaap:RelatedPartyMember 2026-01-01 2026-03-31 0002063816 inacu:SponsorMember 2025-01-01 2025-03-31 0002063816 inacu:SponsorMember 2026-01-01 2026-03-31 0002063816 inacu:SponsorMember 2025-06-30 2025-06-30 0002063816 inacu:PromissoryNoteMember us-gaap:RelatedPartyMember 2025-07-07 2025-07-07 0002063816 inacu:PromissoryNoteMember us-gaap:RelatedPartyMember 2025-07-02 2025-07-02 0002063816 inacu:PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember inacu:SponsorMember 2025-06-13 0002063816 inacu:PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember inacu:SponsorMember 2025-04-17 0002063816 inacu:PromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember inacu:SponsorMember 2025-03-25 0002063816 inacu:FounderMember 2025-06-30 2025-06-30 0002063816 inacu:EBCHIndigoLLCMember inacu:FounderMember 2025-06-30 0002063816 inacu:EBCHIndigoLLCMember inacu:SponsorMember 2025-06-30 2025-06-30 0002063816 inacu:ThirdPartyMember 2025-06-30 2025-06-30 0002063816 inacu:EBCHoldingsIncMember srt:DirectorMember 2025-03-07 0002063816 inacu:EBCHoldingsIncMember srt:DirectorMember 2025-03-07 2025-03-07 0002063816 inacu:EBCHoldingsIncMember inacu:FounderMember 2025-03-07 0002063816 inacu:EBCHoldingsIncMember inacu:SponsorMember 2025-03-07 2025-03-07 0002063816 inacu:EBCHoldingsIncMember 2025-03-07 2025-03-07 0002063816 inacu:EBCHoldingsIncMember inacu:SponsorMember 2025-03-07 0002063816 2025-07-11 2025-07-11 0002063816 2026-03-31 2026-03-31 0002063816 inacu:EBCHoldingsIncMember inacu:SponsorMember 2024-06-07 0002063816 inacu:EBCHoldingsIncMember inacu:SponsorMember 2024-06-07 2024-06-07 0002063816 inacu:BusinessCombinationMember inacu:FounderMember 2026-03-31 0002063816 inacu:BusinessCombinationMember inacu:FounderMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember us-gaap:IPOMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember inacu:FounderMember us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember inacu:FounderMember us-gaap:IPOMember 2025-07-11 0002063816 inacu:BusinessCombinationMember inacu:SponsorMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember inacu:SponsorMember inacu:PrivatePlacementUnitsMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember 2025-07-11 2025-07-11 0002063816 inacu:BusinessCombinationMember us-gaap:PrivatePlacementMember 2025-07-11 2025-07-11 0002063816 inacu:BusinessCombinationMember inacu:SponsorMember 2025-07-11 2025-07-11 0002063816 inacu:BusinessCombinationMember inacu:SponsorMember us-gaap:PrivatePlacementMember 2025-07-11 2025-07-11 0002063816 inacu:BusinessCombinationMember inacu:EBCMember us-gaap:PrivatePlacementMember 2025-07-11 2025-07-11 0002063816 inacu:BusinessCombinationMember inacu:EBCMember us-gaap:PrivatePlacementMember 2025-07-11 0002063816 inacu:BusinessCombinationMember inacu:EBCMember us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember inacu:SponsorMember us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0002063816 inacu:BusinessCombinationMember us-gaap:PrivatePlacementMember 2026-03-31 0002063816 us-gaap:CommonStockMember 2025-07-11 2025-07-11 0002063816 inacu:PublicRightMember 2025-07-11 2025-07-11 0002063816 inacu:BusinessCombinationMember us-gaap:OverAllotmentOptionMember 2025-07-11 2025-07-11 0002063816 us-gaap:OverAllotmentOptionMember 2025-07-11 2025-07-11 0002063816 us-gaap:IPOMember 2025-07-02 2025-07-02 0002063816 us-gaap:IPOMember 2025-07-02 0002063816 inacu:NonRedeemableOrdinaryShareMember 2025-01-01 2025-03-31 0002063816 inacu:NonRedeemableOrdinaryShareMember 2026-01-01 2026-03-31 0002063816 inacu:RedeemableOrdinarySharesMember 2026-01-01 2026-03-31 0002063816 2025-12-31 0002063816 2025-01-01 2025-12-31 0002063816 inacu:PublicShareMember 2026-03-31 0002063816 inacu:IndigoSponsorGroupLLCMember 2026-01-01 2026-03-31 0002063816 us-gaap:IPOMember inacu:IndigoSponsorGroupLLCMember 2026-01-01 2026-03-31 0002063816 us-gaap:PrivatePlacementMember inacu:IndigoSponsorGroupLLCMember 2025-07-11 2025-07-11 0002063816 us-gaap:PrivatePlacementMember inacu:IndigoSponsorGroupLLCMember 2025-07-11 0002063816 inacu:EBCMember inacu:IndigoSponsorGroupLLCMember 2025-07-11 2025-07-11 0002063816 inacu:SponsorMember inacu:IndigoSponsorGroupLLCMember 2025-07-11 2025-07-11 0002063816 inacu:EBCMember us-gaap:PrivatePlacementMember inacu:EarlyBirdCapitalIncMember 2025-07-02 0002063816 inacu:SponsorMember us-gaap:PrivatePlacementMember inacu:EarlyBirdCapitalIncMember 2025-07-02 0002063816 us-gaap:PrivatePlacementMember inacu:EarlyBirdCapitalIncMember 2025-07-02 0002063816 us-gaap:PrivatePlacementMember inacu:EarlyBirdCapitalIncMember 2025-07-02 2025-07-02 0002063816 us-gaap:IPOMember inacu:IndigoSponsorGroupLLCMember 2025-07-02 2025-07-02 0002063816 2025-03-31 0002063816 2025-03-07 2025-03-07 0002063816 us-gaap:RetainedEarningsMember 2025-03-31 0002063816 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002063816 us-gaap:CommonStockMember 2025-03-31 0002063816 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002063816 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0002063816 2024-12-31 0002063816 us-gaap:RetainedEarningsMember 2024-12-31 0002063816 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002063816 us-gaap:CommonStockMember 2024-12-31 0002063816 us-gaap:RetainedEarningsMember 2026-03-31 0002063816 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002063816 us-gaap:RetainedEarningsMember 2025-12-31 0002063816 inacu:NonRedeemableOrdinarySharesMember 2025-01-01 2025-03-31 0002063816 inacu:NonRedeemableOrdinarySharesMember 2026-01-01 2026-03-31 0002063816 inacu:OrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-03-31 0002063816 2026-05-08 0002063816 inacu:RightsEachEntitlingHolderToOneTenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember 2026-01-01 2026-03-31 0002063816 inacu:OrdinarySharesParValuePerShareMember 2026-01-01 2026-03-31 0002063816 inacu:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-01-01 2026-03-31 0002063816 inacu:OrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0002063816 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002063816 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002063816 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002063816 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002063816 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0002063816 inacu:RedeemableOrdinarySharesMember 2025-01-01 2025-03-31 iso4217:USD inacu:segment shares pure iso4217:USD shares

http://fasb.org/srt/2026#ChiefFinancialOfficerMember

00-0000000

Q1 false 0002063816 --12-31 10-Q true 2026-03-31 2026 false 001-42721 INDIGO ACQUISITION CORP. E9 3250 Mary Street Suite 410 Miami FL 33133 (305) 438-7700 Units, each consisting of one ordinary share and one right INACU NASDAQ Ordinary Shares, par value $0.0001 per share INAC NASDAQ Rights, each entitling the holder to one tenth of one ordinary share upon the completion of the Company’s initial business combination INACR NASDAQ Yes Yes Non-accelerated Filer true true false true 14755000

458473

666920

156346

93208

614819

760128

2773

25463

118334352

117298371

118951944

118083962

3418

9042

75000 75000

78418

84042

4025000

4103418

4109042

11500000

10.29

10.2

118334352

117298371

0.0001

20000000

0.0001

200000000

3255000

326

-3486152

-3323777

-3485826

-3323451

118951944

118083962

162375

25870

-162375

-25870

108750

1035981

-108750

873606

-134620

11500000

0.06

3255000

2500000

0.06

-0.05

375000

3255000

326

-3323777

-3323451

1035981

873606

3255000

326

-3486152

-3485826

2875000

288

4712

-18682

-13682

108750

-134620

2875000

288

113462

-153302

-39552

375000

2165000 105000 190379

873606

-134620

1035981

108750

40448

-5624

-208447

-25870

2156

95000

18100

27156

51900

-208447

26030

666920

458473

26030

4998 1650

1035981

10000000

100000000

350000

3500000

350000 225000 125000 1500000

15000000

30000 19286 10714

300000

6741773

2300000

4025000 416773 0.80 0.50

115000000

0.15 1 1

100000

458473

536401

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC on March 26, 2026. The interim results for the three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the unaudited condensed financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $458,473 and $666,920 in cash and no cash equivalents as of March 31, 2026 and December 31, 2025, respectively. Marketable Securities Held in Trust Account As of March 31, 2026 and December 31, 2025, the assets held in the Trust Account, amounting to $118,334,352 and $117,298,371, respectively, were held in a Money Market Mutual Fund. The investments held in the Trust Account are classified as trading securities and are recorded at fair value. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist of underwriting, legal, and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering and were charged to shareholders’ deficit upon the completion of the Initial Public Offering. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited condensed financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OBBA”). The Company is currently evaluating the impact of this legislation. Based on the Company’s preliminary assessment, the provisions of the OBBA are not expected to have a material impact on the Company’s unaudited condensed financial statements. ASC 740 prescribes a recognition threshold and a measurement attribute for the unaudited condensed financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the unaudited condensed balance sheet, primarily due to their short-term nature. Ordinary Shares Subject to Possible Redemption The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial business combination within the completion window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of March 31, 2026 and December 31, 2025 the ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s unaudited condensed balance sheet. As of March 31, 2026 and December 31, 2025, the ordinary shares subject to possible redemption reflected in the unaudited condensed balance sheet are reconciled in the following table: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 88%; text-align: left">Gross proceeds</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">115,000,000</td> <td style="width: 1%; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td>Less:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left">Proceeds allocated to Public Rights</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(2,530,000</td> <td style="text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left">Proceeds allocated to over-allotment</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(127,802</td> <td style="text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left">Ordinary shares issuance cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(6,572,939</td> <td style="text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td>Plus:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">11,529,112</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left">Ordinary Shares subject to possible redemption, December 31, 2025</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">117,298,371</td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td>Plus:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-bottom: 1.5pt">Remeasurement of carrying value to redemption value</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,035,981</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left; padding-bottom: 2.5pt">Ordinary Shares subject to possible redemption, March 31, 2026</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">118,334,352</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table> Share-Based Compensation The Company records share-based compensation in accordance with FASB ASC Topic 718, “Compensation-Share Compensation” (“ASC 718”), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments are valued by multiplying the marketable value per Founder Share (defined in Note 5) by the probability of successful closing of an initial Business Combination. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statement of operations. Share Rights The Company accounts for the public and private placement rights issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the rights under equity treatment at their assigned values. Net (Loss) Income per Share The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as ordinary shares subject to possible redemption and non-redeemable ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period. Diluted net income (loss) per share attributable to ordinary shareholders adjusts the basic net income (loss) per share attributable to ordinary shareholders and the weighted-average ordinary shares outstanding for the potentially dilutive impact of private placement. The Company has not considered the effect of the public and private placement warrants and rights in the calculation of diluted earnings per share, as their exercise is contingent upon the completion of a Business Combination and therefore they are not currently dilutive. With respect to the accretion of ordinary shares subject to possible redemption and consistent with ASC Topic 480-10-S99-3A, the Company treated accretion in the same manner as a dividend paid to the shareholders in the calculation of the net income (loss) per ordinary share. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended March 31,</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; font-style: italic; text-indent: -0.125in">Basic and diluted net income (loss) per ordinary share</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in">Numerator:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-left: 0.125in; width: 52%; text-align: left; text-indent: -0.125in">Allocation of net income (loss)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">680,886</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">192,720</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">—</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(134,620</td> <td style="width: 1%; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in">Basic and diluted weighted average ordinary shares outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">11,500,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">3,255,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,500,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in">Basic and diluted net income (loss) per ordinary share</td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.06</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.06</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(0.05</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td> </tr></tbody></table> Recent Accounting Standards Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

458473

666920

118334352

117298371

As of March 31, 2026 and December 31, 2025, the ordinary shares subject to possible redemption reflected in the unaudited condensed balance sheet are reconciled in the following table:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 88%; text-align: left">Gross proceeds</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">115,000,000</td> <td style="width: 1%; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td>Less:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left">Proceeds allocated to Public Rights</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(2,530,000</td> <td style="text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left">Proceeds allocated to over-allotment</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(127,802</td> <td style="text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left">Ordinary shares issuance cost</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(6,572,939</td> <td style="text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td>Plus:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">11,529,112</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left">Ordinary Shares subject to possible redemption, December 31, 2025</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">117,298,371</td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td>Plus:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-bottom: 1.5pt">Remeasurement of carrying value to redemption value</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,035,981</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="text-align: left; padding-bottom: 2.5pt">Ordinary Shares subject to possible redemption, March 31, 2026</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">118,334,352</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> </tr></tbody></table>

115000000

2530000

-127802

6572939

11529112

117298371

1035981

118334352

Net (Loss) Income per Share The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as ordinary shares subject to possible redemption and non-redeemable ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period. Diluted net income (loss) per share attributable to ordinary shareholders adjusts the basic net income (loss) per share attributable to ordinary shareholders and the weighted-average ordinary shares outstanding for the potentially dilutive impact of private placement. The Company has not considered the effect of the public and private placement warrants and rights in the calculation of diluted earnings per share, as their exercise is contingent upon the completion of a Business Combination and therefore they are not currently dilutive. With respect to the accretion of ordinary shares subject to possible redemption and consistent with ASC Topic 480-10-S99-3A, the Company treated accretion in the same manner as a dividend paid to the shareholders in the calculation of the net income (loss) per ordinary share. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended March 31,</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; font-style: italic; text-indent: -0.125in">Basic and diluted net income (loss) per ordinary share</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in">Numerator:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-left: 0.125in; width: 52%; text-align: left; text-indent: -0.125in">Allocation of net income (loss)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">680,886</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">192,720</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">—</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(134,620</td> <td style="width: 1%; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in">Basic and diluted weighted average ordinary shares outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">11,500,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">3,255,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,500,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in">Basic and diluted net income (loss) per ordinary share</td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.06</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.06</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(0.05</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td> </tr></tbody></table>

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended March 31,</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-redeemable</td> <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; font-style: italic; text-indent: -0.125in">Basic and diluted net income (loss) per ordinary share</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom"><td style="padding-left: 0.125in; text-indent: -0.125in">Numerator:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-left: 0.125in; width: 52%; text-align: left; text-indent: -0.125in">Allocation of net income (loss)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">680,886</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">192,720</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">—</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(134,620</td> <td style="width: 1%; text-align: left">)</td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-left: 0.125in; text-indent: -0.125in">Denominator:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in">Basic and diluted weighted average ordinary shares outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">11,500,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">3,255,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,500,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in">Basic and diluted net income (loss) per ordinary share</td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.06</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">0.06</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(0.05</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td> </tr></tbody></table>

680886

192720

-134620

11500000

3255000

2500000

0.06

-0.05

100000000

1500000

15000000

1 1 1 NOTE 4 — PRIVATE PLACEMENTS Simultaneously with the closing of the Initial Public Offering, the Sponsor, EBC and their designees purchased an aggregate of 350,000 Private Placement Units at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $3,500,000. Of those 350,000 Private Placement Units, the Sponsor and its designees purchased 225,000 Private Placement Units and EBC purchased 125,000 Private Placement Units. Simultaneously with the closing of the over-allotment option on July 11, 2025, the Company consummated the sale of an additional 30,000 Private Placement Units to the Sponsor and EBC at a price of $10.00 per Unit, generating gross proceeds of $300,000. Of those 30,000 Private Placement Units, the Sponsor and its designees purchased 19,286 Private Placement Units and EBC purchased 10,714 Private Placement Units. Each Private Placement Unit consists of one ordinary share (each, a “Private Share”), and one right (each, a “Private Right”), with each Private Right entitling the holder to receive one-tenth of one ordinary share upon consummation of a Business Combination. The proceeds from the sale of the Private Placement Units was added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units and underlying securities will not be transferable, assignable, or salable until the completion of a Business Combination, subject to certain exceptions. Certain investors (the “non-managing investors”) committed, pursuant to written agreements, and purchased, indirectly through the purchase of non-managing membership interests in the Sponsor, an aggregate of 213,089 Private Placement Units out of the 229,286 Private Placement Units purchased by the Sponsor. In exchange for the non-managing investors purchasing the Private Placement Units allocated to them in connection with the closing of the Initial Public Offering, the Sponsor issued additional membership interests at a nominal purchase price to the non-managing investors reflecting interests in an aggregate of approximately 1.6 million Founder Shares. The agreement with the non-managing investors was entered into directly with the Sponsor and it makes reference to the Private Placement Units and Founder Shares of the Company. The interests and units associated in the agreement are supported on one for one basis with the Company’s underlying Private Placement Units and Founder Shares. The fact that the Sponsor provided the non-managing investors with Founder Shares for their participation in the transaction is considered an inducement and falls under SAB Topic 5A. As such, the Company has obtained a valuation of the Founder Shares, of closing of the over-allotment option date to account for the charge of such transfer of interests to the non-managing investors. The valuation determined the fair value of the Founder Shares to be $1.96 per share as of the closing of the over-allotment option, on July 11, 2025. Since the cost of these interest allocations to the non-managing investors is considered an offering cost, the Company recorded the fair value of this transaction into equity at the closing of the over-allotment option date calculated as 1,645,321 interests in Founder Shares allocated to non-managing investors at a fair value of $1.96,or $3,224,829. The third-party valuation firm valued the Founder Shares as of July 2, 2025. The likelihood of completing the Business Combination was assumed to be 23.0%; the implied ordinary share price was $9.78; and a discount for lack of marketability was 13%. The transferred interests to the non-managing investors are classified as Level 3 at the measurement date due to the use of unobservable inputs including the probability of a Business Combination, and other risk factors. 350000

3500000

350000 225000 125000 30000

300000

30000 19286 10714 1 1 213089 229286 1600000

1.96

1645321

1.96

3224829

0.23

9.78

0.13

2875000

5000

0.0017

375000

2090000

0.0017

3636

75000

25000

0.0017

2090000

710000

75000

108750

1.45

105000

190379

0.50

P20D

95000

70000

10000

174000

1000

10000

30000

1500000 10

P45D 1500000 0.2 2300000 0.035

4025000

200000000

0.0001

one

3255000

375000

0.20 375000 1 1

118334352

117298371

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance.

When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tbody><tr style="vertical-align: bottom"><td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td> </tr><tr style="vertical-align: bottom"><td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt"> </td> </tr><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Formation and operating costs</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">162,375</td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">25,870</td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td> </tr><tr style="vertical-align: bottom; background-color: White"><td style="text-align: left; padding-bottom: 1.5pt">Dividend earn on marketable securities held in Trust Account</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,035,981</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> </tr></tbody></table>

162375

25870

1035981

false false false false Excludes up to 375,000 ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriters (Note 5 and 7). On July 11, 2025, the underwriters exercised their over-allotment option in full and as of such date, 375,000 shares were no longer subject to forfeiture. Includes an aggregate of up to 375,000 ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriters (Note 5 and 7). On July 11, 2025, the underwriters exercised their over-allotment option in full and as of such date, 375,000 shares were no longer subject to forfeiture. On March 7, 2025, EBC (defined in Note 1) transferred 2,165,000 founder shares to the Sponsor (defined in Note 1) and directors. On June 30, 2025, the Sponsor transferred 105,000 ordinary shares to an independent party becoming a member of the Sponsor and EBC transferred 190,379 to EBCH Indigo LLC (Note 5).